BLCO
USDBausch + Lomb Corporation Common Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$12.400
Kõrge
$12.488
Madal
$12.240
Maht
0.40M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
4.4B
Tööstusharu
Medical Instruments & Supplies
Riik
Canada
Kauplemisstatistika
Keskmine maht
0.85M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb ...
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
Bausch + Lomb Corporation (NYSE/TSX:BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb
Barclays Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16
Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and lowers the price target from $19 to $16.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such...
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
PALM BEACH, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Retinal and Fundis Camera market has shown growth in the recent years and is expected to continue for years to come. Fundus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such...
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.